A Quote by Warren Buffett

Great investment opportunities come around when excellent companies are surrounded by unusual circumstances that cause the stock to be misappraised. — © Warren Buffett
Great investment opportunities come around when excellent companies are surrounded by unusual circumstances that cause the stock to be misappraised.
The other dynamic keeping the stock market up - both for technology stocks and others - is that companies are using a lot of their income for stock buybacks and to pay out higher dividends, not make new investment,. So to the extent that companies use financial engineering rather than industrial engineering to increase the price of their stock you're going to have a bubble. But it's not considered a bubble, because the government is behind it, and it hasn't burst yet.
We monitor close to 50 companies globally that can be potential investment opportunities. I'd like to see DST as a significant global investment company in the Internet arena.
The London property market has excellent investment opportunities.
There is no question that an important service is provided to investors by investment companies, investment advisors, trust departments, etc. This service revolves around the attainment of adequate diversification, the preservation of a long-term outlook, the ease of handling investment decisions and mechanics, and most importantly, the avoidance of the patently inferior investment techniques which seem to entice some individuals.
I come from great stock. I didn't come from money. My parents both worked really hard to keep food on the table and give my sister and me opportunities to play sports and see what we were good at.
The vast majority of companies don't go public and mint dozens of millionaires. And most companies don't go around doling out stock options; private companies tend to be very tight about ownership.
The great personal fortunes in the country weren't built on a portfolio of fifty companies. They were built by someone who identified one wonderful business. With each investment you make, you should have the courage and the conviction to place at least 10% of your net worth in that stock.
President Trump has the advantage of being surrounded by an excellent cadre of advisors. Kim Jong-un doesn't have any advisors that are going to give him objective counsel. He's surrounded by medal-bedecked sycophants, who dutifully follow him around like puppy dogs with their notebooks open, ascribing his every utterance, and pushing back against the great leader is not a way to get ahead.
Pubcon is always one of the first shows I put on my calendar. Content is excellent, social is excellent, networking opportunities are excellent.
I am proud of the fact that the U.K. is an open trading country. I welcome inward investment such as that of Nissan, and the takeover of struggling British companies by foreign companies who turn them around, as in the case of Jaguar Land Rover. I also accept that job losses sometimes have to occur to restore failing companies to health.
A great company is not a great investment if you pay too much for the stock.
What an economy really wants, after all, is not more investment per se but better investment. It wants capital to flow to companies that will create value - not in the form of a rising stock price but in the form of more goods for less cost, more jobs, and rising wages - by enhancing productivity.
Although there are good and bad companies, there is no such thing as a good stock; there are only good stock prices, which come and go.
When high-growth companies slow down, growth and momentum junkies often sell indiscriminately, which can create great opportunities for value investors. Just be careful not to anchor on the stock's previous price or earnings multiple, which are no longer relevant.
Unfortunately our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very-very strong balance sheet with huge value drivers at the end of it.
Unfortunately, our stock is somehow not well understood by the markets. The market compares us with generic companies. We need to look at Biocon as a bellwether stock. A stock that is differentiated, a stock that is focused on R&D, and a very, very strong balance sheet with huge value drivers at the end of it.
This site uses cookies to ensure you get the best experience. More info...
Got it!